Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease　― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―-Reference-Cited by-同舟云学术

Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease　― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―

Published:2021-01-25 Issue:2 Volume:85 Page:130-138
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hisatome Ichiro¹,Li Peili¹,Miake Junichiro²,Taufiq Fikri³,Mahati Endang⁴,Maharani Nani⁴,Utami Sulistiyati Bayu⁵,Kuwabara Masanari⁶,Bahrudin Udin⁵,Ninomiya Haruaki⁷

Affiliation:

1. Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science

2. Department of Pharmacology, Tottori University Faculty of Medicine

3. Department of Physiology, Faculty of Medicine, Sultan Agung Islamic University

4. Department of Pharmacology and Therapy, Faculty of Medicine, Diponegoro University

5. Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University

6. Intensive Care Unit and Department of Cardiology, Toranomon Hospital

7. Department of Biological Regulation, Tottori University Faculty of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/85/2/85_CJ-20-0406/_pdf

Reference75 articles.

1. 1. Yamanaka H. Japanese guideline for the management of hyperuricemia and gout: Second edition. Nucleosides Nucleotides Nucleic Acids 2011; 30: 1018–1029.

2. 2. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken) 2020; 72: 744–760.

3. 3. Hisatome I, Ichida K, Mineo I, Ohtahara A, Ogino K, Kuwabara M, et al. Japanese Society of Gout and Uric & Nucleic Acids 2019 Guidelines for Management of Hyperuricemia and Gout 3rd edition. Gout and Uric & Nucleic Acids 2020; 44: sp-1–sp-40.

4. 4. Allen DJ, Milosovich G, Mattocks AM. Inhibition of monosodium urate needle crystal growth. Arthritis Rheum 1965; 8: 1123–1133.

5. 5. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972; 15: 189–192.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28

2. Proteolysis-resistant extracellular uricase from the sponge-derived Streptomyces rochei;Biocatalysis and Biotransformation;2024-08-21

3. The association between dietary antioxidant quality score and uric acid related mortality in patients with chronic kidney disease;Frontiers in Nutrition;2024-07-12

4. Dispel some mist on circulating biopterins: measurement, physiological interval and pathophysiological implication;Metabolomics;2024-07-09

5. Hyperuricemia as a risk factor for cerebral hemorrhage in young and middle-aged hypertensive patients at high altitude;Neurology Asia;2024-06